PATH is an international nonprofit organization that transforms global health through innovation. Their approach blends the entrepreneurial spirit of business, the scientific expertise of a research institution, and the passion and on-the-ground experience of an international NGO. For nearly 40 years, they have been pioneers in the development and delivery of health solutions. They accelerate smart ideas and mobilize partners to reach the world’s most vulnerable women and children. Their work spans five platforms: vaccines, devices, diagnostics, drugs, and system and service innovations. It bridges borders, sectors, and disciplines to shape the next generation of health innovations and maximize their lifesaving potential.
As part of a maternal health technology assessment project, PATH created an Excel-based Strategic Prioritization Tool (SPT) to assess and prioritize nearly 40 technologies that address postpartum hemorrhage and preeclampsia/eclampsia for their potential to have impact in low-resource settings. The tool—which relies largely on information that can be collected from secondary data sources—scores evaluation criteria, each representing a discrete element of the technology’s value proposition and overall potential for impact.  To learn more about PATH’s strategic prioritization tool, please click here.